EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Divergent roles of RIPK3 and MLKL in high-fat diet–induced obesity and MAFLD in mice

Hazel Tye, Stephanie A Conos iD, Tirta M Djajawi, Timothy A Gottschalk iD, Nasteho Abdoulkader iD, Isabella Y Kong, Helene L Kammoun, Vinod K Narayana iD, Tobias Kratina, Mary Speir, Jack Emery, Daniel S Simpson und 16 weitere

Life Science Alliance · 2025

DOI: 10.26508/lsa.202302446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Hazel Tye und 27 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Australia. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Diet, High-Fat, Obesity, Protein Kinases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DHAC | National Health and Medical Research Council, Department of Education and Training | Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell death frequently occurs in the pathogenesis of obesity and metabolic dysfunction–associated fatty liver disease (MAFLD). However, the exact contribution of core cell death machinery to disease manifestations remains ill-defined. Here, we show via the direct comparison of mice genetically deficient in the essential necroptotic regulators, receptor-interacting protein kinase-3 (RIPK3) and mixed lineage kinase domain–like (MLKL), as well as mice lacking apoptotic caspase-8 in myeloid cells combined with RIPK3 loss, that RIPK3/caspase-8 signaling regulates macrophage inflammatory responses and drives adipose tissue inflammation and MAFLD upon high-fat diet feeding. In contrast, MLKL, divergent to RIPK3, contributes to both obesity and MAFLD in a manner largely independent of inflammation. We also uncover that MLKL regulates the expression of molecules involved in lipid uptake, transport, and metabolism, and congruent with this, we discover a shift in the hepatic lipidome upon MLKL deletion. Collectively, these findings highlight MLKL as an attractive therapeutic target to combat the growing obesity pandemic and metabolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor-Interacting Protein Serine-Threonine KinasesDiet, High-FatObesityProtein KinasesAnimalsMiceMice, KnockoutCaspase 8MaleMice, Inbred C57BLSignal TransductionFatty LiverInflammationLiverMacrophagesNecroptosisApoptosisAdipose TissueNon-alcoholic Fatty Liver Disease

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesMLKL protein, mouseRipk3 protein, mouseProtein KinasesCaspase 8Casp8 protein, mouse

Autor:innen und Institutionen

  • Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Australia.
  • Department of Molecular and Translational Science, Monash University, Clayton, Australia.
  • The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • The Department of Medical Biology, University of Melbourne, Parkville, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Metabolomics Australia, Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, Melbourne, Australia.

ORCID-Profile: Stephanie A Conos, Timothy A Gottschalk, Nasteho Abdoulkader, Vinod K Narayana, Joanne M Hildebrand, James M Murphy, Kate E Lawlor

Förderung

  • DHAC | National Health and Medical Research Council
  • Department of Education and Training | Australian Research Council

Zitieren

APA

Tye, H., Conos, S. A., Djajawi, T. M., Gottschalk, T. A., Abdoulkader, N., Kong, I. Y., Kammoun, H. L., Narayana, V. K., Kratina, T., Speir, M., Emery, J., Simpson, D. S., Hall, C., Vince, A. J., Russo, S., Crawley, R., Rashidi, M., Hildebrand, J. M., Murphy, J. M., …, & Lawlor, K. E. (2025). Divergent roles of RIPK3 and MLKL in high-fat diet–induced obesity and MAFLD in mice. Life Science Alliance. https://doi.org/10.26508/lsa.202302446

Vancouver

Tye H, Conos SA, Djajawi TM, Gottschalk TA, Abdoulkader N, Kong IY, et al. Divergent roles of RIPK3 and MLKL in high-fat diet–induced obesity and MAFLD in mice. Life Science Alliance. 2025. doi:10.26508/lsa.202302446

BibTeX
@article{Tye2025,
  author = {Tye, Hazel and Conos, Stephanie A and Djajawi, Tirta M and Gottschalk, Timothy A and Abdoulkader, Nasteho and Kong, Isabella Y and Kammoun, Helene L and Narayana, Vinod K and Kratina, Tobias and Speir, Mary and Emery, Jack and Simpson, Daniel S and Hall, Cathrine and Vince, Angelina J and Russo, Sophia and Crawley, Rhiannan and Rashidi, Maryam and Hildebrand, Joanne M and Murphy, James M and Whitehead, Lachlan and De Souza, David P and Masters, Seth L and Samson, Andre L and Lalaoui, Najoua and Hawkins, Edwin D and Murphy, Andrew J and Vince, James E and Lawlor, Kate E},
  title = {Divergent roles of RIPK3 and MLKL in high-fat diet–induced obesity and MAFLD in mice},
  journal = {Life Science Alliance},
  year = {2025},
  doi = {10.26508/lsa.202302446}
}
Kostenlos starten →